VTAK (Catheter Precision, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by VTAK officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | PHILIP J ANDERSON | Chief Financial Officer | A | — | — |
| 2026-03-30 | MARTIN J COLOMBATTO | Director | A | — | — |
| 2026-03-30 | Andrew Arno | Director | A | — | — |
| 2026-03-30 | James Joseph Caruso | Director | A | — | — |
| 2026-03-30 | DAVID A JENKINS | Chairman of the Board and CEO | A | — | — |
| 2026-02-18 | DAVID A JENKINS | Chairman of the Board and CEO | J | — | — |
| 2026-01-20 | DAVID A JENKINS | Chairman of the Board and CEO | J | — | — |
| 2025-12-08 | James Joseph Caruso | Director | C | — | — |
| 2025-12-08 | DAVID A JENKINS | Chairman of the Board and CEO | C | — | — |
| 2025-08-14 | MARTIN J COLOMBATTO | Director | A | — | — |
| 2025-08-14 | James Joseph Caruso | Director | A | — | — |
| 2025-08-14 | Andrew Arno | Director | A | — | — |
| 2025-08-14 | DAVID A JENKINS | Exec. Chairman of the Board | A | — | — |
| 2025-03-03 | PHILIP J ANDERSON | Chief Financial Officer | A | — | — |
| 2025-01-31 | James Joseph Caruso | Director | A | — | — |
| 2025-01-31 | Marie-Claude Jacques | Chief Commercial Officer | A | — | — |
| 2025-01-31 | DAVID A JENKINS | Chairman of the Board and CEO | A | — | — |
| 2025-01-31 | MARTIN J COLOMBATTO | Director | Sell | — | — |
| 2025-01-31 | Andrew Arno | Director | A | — | — |
| 2024-05-03 | Marie-Claude Jacques | Chief Commercial Officer | A | — | — |
| 2024-01-24 | DAVID A JENKINS | Executive Chairman and CEO | Buy | — | — |
| 2024-01-22 | DAVID A JENKINS | Executive Chairman and CEO | Buy | — | — |
| 2024-01-18 | DAVID A JENKINS | Executive Chairman and CEO | Buy | — | — |
| 2024-01-10 | MARTIN J COLOMBATTO | Director | A | — | — |
| 2024-01-10 | James Joseph Caruso | Director | A | — | — |
| 2024-01-10 | John P. Francis | Director | A | — | — |
| 2024-01-10 | Margrit Thomassen | Interim CFO and Secretary | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chairman of the Board and CEO | 13,908 | — |
| — | Director | 50 | — |
| — | Director | 3 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the VTAK quote page; the site-wide leaderboard is on the insider transactions hub.